课题基金 / 基金详情

Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma and application for diagnosis and treatment

Molecular mechanisms of intrahepatic metastasis of hepatocellular carcinoma and application for diagnosis and treatment
肝细胞癌肝内转移的分子机制及其在诊疗中的应用
批准号:
12470049
负责人:
SAKAMOTO Michiie
金额:
$3.65万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SAKAMOTO Michiie的其他基金

相似基金

相关文献

中文摘要
翻译
肝内转移是影响肝细胞癌预后的重要因素之一。由rho和p160 rho相关的卷曲卷曲形成蛋白激酶(p160ROCK)信号通路介导的细胞运动最近被证明在人类HCC的肝内转移中起关键作用。其中一种高度转移的细胞系,具有高水平c-Src激酶活性的KYN-2细胞在贴壁状态下变得分散,延伸板足,并表现出高运动性。显性阴性突变型c-Src的表达导致应力纤维的形成和局灶粘连,并显著降低运动性。这表明c-Src激活在癌细胞迁移和转移中起关键作用。为了研究特异性p160ROCK抑制剂Y-27632是否也能抑制肝内转移,我们研究了Y-27632对Li7细胞运动和肝内转移的影响。Y-27632明显阻断肌动蛋白重组,提高溶血磷脂酸介导的Li7细胞的组织和运动能力。Y-27632通过微渗透泵连续注入腹腔,同时将Li7细胞原位植入SCID小鼠肝脏。y -27632治疗组小鼠转移性结节发生率降低。这些发现证实了Rho/p160ROCK信号通路在人肝癌肝内转移中的重要性,提示Y-27632可能对预防人肝癌肝内转移有一定作用。采用差异显示分析方法筛选肝癌转移相关关键基因。一个新的基因,DRH1,在HCC中经常被下调。CO-029在HCC和肝内扩散的肿瘤中频繁且显著过表达。相比之下,其他四跨蛋白CD9和CD82的mRNA表达在HCC中下调,特别是在肝内扩散的肿瘤中。提示CO-029在促进肝癌转移中有一定作用。少
英文摘要
Intrahepatic metastasis is one of the most important prognostic factors for patients with hepatocellular carcinoma (HCC). Cell motility mediated by Rho-and p160 Rho-associated coiled-coil forming protein kinase (p160ROCK) signaling pathways has recently been shown to play a critical role in intrahepatic metastasis in human HCC. One of such highly metastatic cell line, KYN-2 cells having a high level of c-Src kinase activity become scattered, extend lamellipodia, and exhibit high motility in adherent condition. Expression of a dominant-negative mutant form of c-Src caused formation of stress fibers and focal adhesions, and markedly reduced motility. it was suggested that c-Src activation is critically involved in carcinoma cell migration and metastasis. To investigate whether the specific p160ROCK inhibitor Y-27632 could also inhibit intrahepatic metastasis, the effect of Y-27632 on the cell motility and intrahepatic metastasis of Li7 was investigated. Y-27632 markedly blocked actin reo … More rganization and motility of Li7 cells mediated by lysophosphatidic acid. Y-27632 was administered continuously into the peritoneal cavity using a micro-osmotic pump, together with orthotopic implantation of Li7 cells into the liver of SCID mice. The incidence of mice with metastatic nodules decreased in the Y-27632-treated group. These findings confirm the importance of the Rho/p160ROCK signaling pathway in intrahepatic metastasis of human HCC, and indicate that Y-27632 may be useful for the prevention of intrahepatic metastasis of human HCC.Crucial genes involved in liver cancer metastasis were screened using differential display analysis. A novel gene, DRH1, which is frequently down-regulated in HCC was identified. CO-029 was found to be frequently and significantly overexpressed in HCC and in tumors with intrahepatic spreading. In contrast, mRNA expression of the other tetraspanins CD9 and CD82 was down-regulated in HCC, especially in tumors with intrahepatic spreading. It was suggested that CO-029 has some roles in the promotion of metastasis of HCC. Less
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takamura,M.,Sakamoto,M.,Genda,T.,Ichida,T.,Asakura,H.,Hirohashi,S.: "Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632."Hepatology. (In press). (2001)
Takamura,M.、Sakamoto,M.、Genda,T.、Ichida,T.、Asakura,H.、Hirohashi,S.:“Rho 相关蛋白激酶抑制剂 Y-27632 抑制人肝细胞癌肝内转移。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kengo Kanetaka, Michiie Sakamoto, Yoshiya Yamamoto, Susumu Yamasaki, Francois Lanza, Takashi Kanematsu, Setsuo Hirohashi: "Overexpression of tetraspanin CO-029 in hepatocellular carcinoma"J. Hepatol.. 35. 637-642 (2001)
Kengo Kanetaka、Michiie Sakamoto、Yoshiya Yamamoto、Susumu Yamasaki、Francois Lanza、Takashi Kanematsu、Setsuo Hirohashi:“肝细胞癌中四跨膜蛋白 CO-029 的过度表达”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto Y., Sakamoto., et al.: "Cloning and characterization of a novel gene, DRHJ, down-regulated in advanced human hepatocellular carcinoma."Clin. Cancer Res.. 7(2). 297-303 (2001)
Yamamoto Y.、Sakamoto. 等人:“新基因 DRHJ 的克隆和表征,该基因在晚期人类肝细胞癌中下调。”Clin。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Establishing the molecular pathology-based subclassification of hepatocellular carcinoma.
    • 批准号:
      26293081
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.23万
    • 财政年份:
      2014
    • 负责人:
      SAKAMOTO Michiie
    • 依托单位:
    Expression and functional analyses of G protein-coupled receptor GPR49/LGR5 in human tissues and diseases
    • 批准号:
      21390108
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2009
    • 负责人:
      SAKAMOTO Michiie
    • 依托单位:
    Development of individualized diagnosis for cancer of digestive organ
    • 批准号:
      17015042
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $42.69万
    • 财政年份:
      2005
    • 负责人:
      SAKAMOTO Michiie
    • 依托单位:
    Molecular mechanisms of progression and metastasis of hepatocellular carcinoma and their application on diagnosis and therapy.
    • 批准号:
      15390118
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2003
    • 负责人:
      SAKAMOTO Michiie
    • 依托单位:
    海外基金